Effects of gold on cytokine production in vitro; increase of monocyte dependent interleukin 10 production and decrease of interferon-gamma levels

J Rheumatol. 2002 Jan;29(1):21-8.

Abstract

Objective: To investigate the effects of gold salt on the differential production of proinflammatory and antiinflammatory cytokines in vitro.

Methods: Heparinized blood from 10 blood donors and 10 patients with polyarthritis was density separated and incubated with various concentrations of gold salt [Myocrisin gold sodium thiomalate (GSTM) plus phenyl mercury nitrate]. Cytokine production was measured after incubation for 16-20 h using an Elispot method detecting interleukin 10 (IL-10), IL-6, tumor necrosis factor-alpha (TNF-alpha), and interferon-gamma (IFN-gamma) producing cells. In addition, parallel cell culture supernatants were collected and analyzed by ELISA for IL-10, IL-6, TNF-alpha, IFN-gamma, and IL-2. In some cultures phytohemagglutinin A (PHA) was added in predefined concentrations.

Results: GSTM increased the number of cells producing IL-6 and IL-10 in a dose dependent manner, both with and without simultaneous addition of PHA. These effects were seen in samples from both healthy blood donors and patients with polyarthritis. The increase in IL-10 production was inhibited when monocytes were depleted. No effects of GSTM were seen on IFN-gamma or TNF-alpha producing cells. Parallel supernatant cultures displayed a GSTM dose dependent decrease in IFN-gamma levels after mitogen stimulation, whereas no changes were seen in IL-6 or TNF-alpha levels.

Conclusion: The differential effects of gold salt on cytokine production, with a marked stimulatory effect on IL- 10 and IL-6, indicate that gold salt may act as a relatively selective immunostimulator rather than as a general immunosuppressant.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, Surface / immunology
  • Antirheumatic Agents / pharmacology*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • Arthritis, Rheumatoid / metabolism
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Down-Regulation / drug effects*
  • Down-Regulation / immunology
  • Female
  • Humans
  • Interferon-gamma / immunology
  • Interferon-gamma / metabolism*
  • Interleukin-10 / immunology
  • Interleukin-10 / metabolism*
  • Interleukin-2 / immunology
  • Interleukin-2 / metabolism
  • Interleukin-6 / immunology
  • Interleukin-6 / metabolism
  • Leukocytes, Mononuclear / drug effects*
  • Leukocytes, Mononuclear / immunology
  • Leukocytes, Mononuclear / metabolism
  • Male
  • Middle Aged
  • Monocytes / drug effects
  • Monocytes / immunology
  • Monocytes / metabolism
  • Organogold Compounds
  • Up-Regulation / drug effects*
  • Up-Regulation / immunology

Substances

  • Antigens, Surface
  • Antirheumatic Agents
  • Interleukin-2
  • Interleukin-6
  • Organogold Compounds
  • Interleukin-10
  • Interferon-gamma